Your SlideShare is downloading. ×

Aco webinar slides

1,159

Published on

These are the slides displayed during the September 28th webinar on Understanding the Importance of ACOs presented by ROI2 and hosted by Dr. Barry Mennen, MD. With Matt Eyles and Jim Smith.

These are the slides displayed during the September 28th webinar on Understanding the Importance of ACOs presented by ROI2 and hosted by Dr. Barry Mennen, MD. With Matt Eyles and Jim Smith.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,159
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
29
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Understanding the Importance of ACOs: Accountable Care Organizations in Today’s Healthcare Environment Follow ROI2 on Twitter @Influence_Intel and join us as we live Tweet today's webinar: #ACO Copyright 2011 | ROI2 Inc Proprietary and Confidential
  • 2.
    • March 31, 2011: HHS releases proposal with new rules for enhancing coordinated care among Medicare patients
      • “ Accountable Care Organizations”
    • Seeks efficiencies and adherence to standards to improve care and lower costs
    • The electronic health record will enable integration, coordination and monitoring
    • Will incentivize providers with monetary rewards for performance
    ACOs Briefly – Barry Mennen, MD Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 3.
    • Payers at all levels--employers, government, individuals—have reached the limits of affordability under the current cost structure of health care in the U.S.
    • Payer adoption of ACO-type models is moving ahead despite challenges with the approach for the Medicare program
    • Insurers are seeking to align incentives better with health systems/hospitals and PCPs/providers to provide better care, better patient experience, lower cost trends
    • No one-size fits-all approach but most ACO initiatives are built on patient-centered medical home concept with enhanced technology (e.g., EMRs) and data sharing
    • Trend toward ACOs will continue no matter what ultimately happens with reform
    Insurer/Payer Perspective - Matt Eyles Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 4.
    • Changing dynamic environment:
      • Sales Impact
        • Sales representatives, sales achievement, forecasting
      • Marketing Impact
        • How to change your marketing strategies to provide “valued” impact
      • Channel Impact on key stakeholders
        • HEOR growth
        • Clinical/Medical (comparative effectiveness models)
        • Financial models
    Pharma Perspective - Jim Smith Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 5.
    • To ask questions of our panelists, please use the GotoWebinar panel on your screen.
    • Please enter your question here and click SEND.
    • We will answer as many questions as time permits.
    Q & A Session Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 6.
    • ACO landscape will continue to rapidly evolve
    • Critical to understand the role of drugs/biologics and devices in different ACO models
    • Better data on outcomes, comparative clinical and cost-effectiveness, and short and long-term therapeutic value are imperative
    • Partnerships with different stakeholders in the development process and post-approval are key
    Summary – Matt Eyles Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 7.
    • Embrace the change:
      • Have the vision to develop strategies that satisfy regardless.
        • EMR will allow ACO’s to analyze based on a comparative and cost effectiveness basis within their own organizations
        • Explore adherence and compliance metrics for therapeutic and cost benefit
        • Partner
          • Deliver on clinical outcomes early in development, provide pathways for cost benefit and the development treatment guidelines
    Summary – Jim Smith Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel
  • 8.
    • Thank you for attending today’s session. If you have any suggestions for new topics, or want to comment on today’s webinar, please send them to:
    • [email_address]
    • A recording of today’s session will be available on the ROI 2 website:
    • www.roi2.com
    • See us at the 6 th Annual PharmaForce Conference!
    • October 3-5, 2011 in Princeton, New Jersey
    • www.pharmaforceus.com
    • Bonnie Rishell (CEO) – [email_address]
    • Barbie Leinheiser (Director Client Services) – [email_address]
    • Kevin Dougherty (VP Sales, Business Development) – [email_address]
    • Bob Latshaw (VP Sales and Marketing) – [email_address]
    Thank you Copyright 2011 | ROI2 Inc Proprietary and Confidential Follow Us @Influence_Intel

×